<DOC>
	<DOCNO>NCT01881971</DOCNO>
	<brief_summary>Hypothesis : Statin therapy decrease inflammation slow progression cardiopulmonary abnormality HIV .</brief_summary>
	<brief_title>Statins Pulmonary Cardiac Complications Chronic HIV - Coordinating Center</brief_title>
	<detailed_description>Growing evidence indicate chronic obstructive pulmonary disease ( COPD ) important cause respiratory impairment HIV+ person likely increase HIV+ population continue age . In HIV-uninfected population , COPD frequently co-exists cardiac disease include atherosclerosis pulmonary hypertension ( PH ) . The investigator work demonstrated syndrome `` cardiopulmonary dysfunction '' exists even non-smoking antiretroviral-treated HIV+ individual . The investigator find HIV+ individual high prevalence respiratory symptom , airflow obstruction , diffuse capacity ( DLco ) abnormalities occur concurrently cardiac co-morbidities , include radiographic measure atherosclerosis elevate echocardiographic pulmonary artery pressure . This syndrome mark inflammation elevate level cytokine hsCRP , peripheral T-cell activation , increase sputum neutrophils well elevation NT-proBNP , marker heart strain . Importantly , investigator show DLco impairment elevate NT-proBNP significant independent predictor mortality HIV , indicate cardiopulmonary dysfunction likely highly clinically relevant identifies vulnerable population investigator lack effective intervention . Statins anti-inflammatory effect lung vasculature might benefit cardiopulmonary dysfunction HIV . These agent long history clinical use cardiovascular disease currently investigate disease-modifying drug HIV , COPD , PH . In preliminary analysis , investigator find HIV+ individual receive statin therapy within past year significantly less likely impaired DLco low pulmonary artery pressure , low NT-proBNP , low peripheral cytokine , few sputum neutrophil despite old great smoke history use statin .</detailed_description>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<criteria>HIV1 infection , document medical record time prior study entry . Men woman age18 year 80 year . Presence COPD ( FEV1/FVC &lt; 0.70 DLcoâ‰¤80 % predict ) No lipidlowering medication ( prescription nonprescription ) within 60 day prior study entry . This include statin drug , omega3fatty acids/fish oil ( dose &gt; 1 g/day ) , red yeast rice ( dose ) , niacin product ( e.g. , niacin , nicotinic acid , vitamin B3 ; dose &gt; 100 mg/day ) Normal liver kidney function test screen visit : Liver function : ALT 7 55 U/L ; AST 8 48 U/L ; ALP 45 115 U/L ; Bilirubin 0.1 1.0 mg/dL ; GGT 9 48 U/L ; LDH 122 222 umol/L ; PT 8.3 10.8 second Kidney function : BUN 820 mg/dl . Creatinine 0.81.2 mg/dl male 0.60.9 mg/dl female . GFR normal result range 90 120 mL/min/1.73 m2 . ) Participants stable ART regimen ( i.e . change agent ) either suppress HIV viral level &lt; 50 viral level least 3 month . If smoker , plan quit smoke study period . If nonsmoker , plan start smoke study period . Able provide inform consent . Able participate study procedure base investigator 's assessment . For woman reproductive potential , negative urine pregnancy test willingness use birth control study period ( see Contraception requirement ) . Ability willingness complete test . Participant MACS , Women 's Interagency Health Study , Attendee UPMC HIV / AIDS Program . Pregnancy breastfeed . Known allergy/sensitivity hypersensitivity HMG CoA reductase inhibitor , prior history myopathy , rhabdomyolysis , intolerance statin therapy . Currently receive statin take statin base clinical criterion . Concurrent use Coumadin . History liver disease . Contraindication pulmonary function test ( i.e . abdominal cataract surgery within 3 month , recent myocardial infarction , etc. ) . Diagnosis asthma normal diffuse capacity . History diabetes mellitus require medication hemoglobin A1C &gt; 6.5 % screen laboratory . Increasing respiratory symptom febrile ( temperature &gt; 100.40F [ 380C ] ) within 4 week study entry . Hospitalization within 4 week prior study entry . Use antibiotic within 4 week study entry . Uncontrolled hypertension screen visit ( systolic &gt; 160 mm Hg diastolic &gt; 100 mm Hg ) average two reading . Subject may return screen blood pressure control . Active cancer require systemic chemotherapy radiation . Active infection lung , brain , abdomen . Use antiinflammatory agent ( aspirin ) , immunomodulators ( e.g. , interleukin , interferon , cyclosporine ) immunosuppressive medication within 60 day prior study entry . Routine vaccination allow administer least 7 day prior study entry . Use azole antifungal , erythromycin , amiodarone . More weekly use magnesium hydroxide . The intention quit smoking study period . Alcoholism define &gt; 35 drink per week impair ability complete study investigation opinion investigator . Active ( within past 6 month ) intravenous drug use impair ability complete study investigation opinion investigator . Use investigational agent within 90 day study entry planning enter another therapy trial study period . No use inhale corticosteroid ( betaagonists allow ) . Viral load 50 past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>lung</keyword>
	<keyword>lipid</keyword>
	<keyword>lipid lower medication</keyword>
	<keyword>normal liver kidney function</keyword>
	<keyword>stable ART regimen</keyword>
	<keyword>pregnant</keyword>
</DOC>